Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Conte-Devolx

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
European Journal of Endocrinology|February 15, 2001
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective studyL Nguyen, P Niccoli-Sire, P Caron, et al.
Annales D'Endocrinologie|April 6, 1999
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]S Richard, S Giraud, C Beroud, et al.
European Journal of Endocrinology|November 27, 1999
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)P Niccoli-Sire, A Murat, E Baudin, et al.
Clinical Endocrinology|May 14, 1998
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonineE Modigliani, R Cohen, J M Campos, et al.
Annales De Chirurgie|September 30, 1998
[Early therapeutic management of patients genetically predisposed to medullary thyroid cancer]A Murat, E Modigliani, B Conte-Devolx, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patientsP Niccoli-Sire, A Murat, V Rohmer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2010
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawalD Taïeb, F Sebag, B Farman-Ara, et al.
European Journal of Endocrinology|March 18, 2009
Merits and pitfalls of mifepristone in Cushing's syndromeF Castinetti, M Fassnacht, S Johanssen, et al.
European Journal of Endocrinology|February 7, 2004
Advances in diagnostic practices affect thyroid cancer incidence in FranceL Leenhardt, M O Bernier, M H Boin-Pineau, et al.
Clinical Endocrinology|September 23, 2008
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled studyD Taïeb, F Sebag, M Cherenko, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
European Journal of Endocrinology|February 15, 2001
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective studyL Nguyen, P Niccoli-Sire, P Caron, et al.
Annales D'Endocrinologie|April 6, 1999
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]S Richard, S Giraud, C Beroud, et al.
European Journal of Endocrinology|November 27, 1999
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)P Niccoli-Sire, A Murat, E Baudin, et al.
Clinical Endocrinology|May 14, 1998
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonineE Modigliani, R Cohen, J M Campos, et al.
Annales De Chirurgie|September 30, 1998
[Early therapeutic management of patients genetically predisposed to medullary thyroid cancer]A Murat, E Modigliani, B Conte-Devolx, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patientsP Niccoli-Sire, A Murat, V Rohmer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2010
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawalD Taïeb, F Sebag, B Farman-Ara, et al.
European Journal of Endocrinology|March 18, 2009
Merits and pitfalls of mifepristone in Cushing's syndromeF Castinetti, M Fassnacht, S Johanssen, et al.
European Journal of Endocrinology|February 7, 2004
Advances in diagnostic practices affect thyroid cancer incidence in FranceL Leenhardt, M O Bernier, M H Boin-Pineau, et al.
Clinical Endocrinology|September 23, 2008
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled studyD Taïeb, F Sebag, M Cherenko, et al.
Pageof 15